Home/Pipeline/OLPRUVA®

OLPRUVA®

Urea Cycle Disorders (UCDs)

ApprovedCommercial

Key Facts

Indication
Urea Cycle Disorders (UCDs)
Phase
Approved
Status
Commercial
Company

About Zevra Therapeutics

Zevra Therapeutics is a purpose-driven rare disease company with a dual focus on commercial execution and late-stage clinical development. Its strategy involves following scientific data to build compelling regulatory narratives that address significant unmet patient needs. With a seasoned leadership team and a pipeline anchored in rare neurological and genetic disorders, Zevra aims to become a leader in the orphan drug space by advancing transformative therapies.

View full company profile